MedPath

Topical Ketoprofen Versus Placebo in Patients With Ankle Sprain

Phase 4
Completed
Conditions
Ankle Sprain
Interventions
Registration Number
NCT02393846
Lead Sponsor
Akdeniz University
Brief Summary

The aim of this study is to analyse the effect of ketoprofen gel in patients presented with ankle sprain to the emergency department.

Detailed Description

Patients, 18-65 years old, presented with ankle sprain are enrolled into the study. Pain over 24 hours, pain intensity lower than 40 mm, allergy to the study drug, drug alcohol abuse and pregnancy or breastfeeding are the exclusion criteria. The study interventions are 2 gr of 2.5% ketoprofen gel versus placebo applied to the sprain area. The study drugs are identical in colour, form and smelling. After an eligible patient presented to the ED, the drug number from an opaque bag is determined by a nurse and then another nurse applies the study drug to the patient. Physicians, nurses and patients are blinded to the study drug. Pain intensity of patients is measured by visual analogue scale at baseline, 15th and 30th minutes after the administration.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
100
Inclusion Criteria
  • Patient presented with ankle sprain to the emergency department.
  • Patients between 18-65 years old.
Exclusion Criteria
  • Pain over 24 hours,
  • Pain intensity lower than 40 mm,
  • allergy to the study drug,
  • drug alcohol abuse
  • pregnancy or breastfeeding are the exclusion criteria.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
PlaceboPlaceboTopical placebo (gel) is identical in colour, form and smell with the ketoprofen gel.
ketoprofenKetoprofen gelTopical ketoprofen (gel) is the experimental drug that is applied to the ankle in a dose of 2 gr.
Primary Outcome Measures
NameTimeMethod
Visual analogue scale30 minutes

Pain intensity is measured by visual analogue scale at baseline, 15 and 30 minutes after the administration.

Secondary Outcome Measures
NameTimeMethod
Adverse effects30 minutes

Adverse effects occurred during the study is recorded to the study form.

Trial Locations

Locations (1)

Pamukkale University

🇹🇷

Denizli, Turkey

© Copyright 2025. All Rights Reserved by MedPath